Echocardiographic monitoring for clozapine cardiac toxicity: lessons from real-world experience
Stuart Murch, Tran Nga, Danny Liew, Melissa Petrakis, David Prior, David Castle
Australasian Psychiatry | SAGE PUBLICATIONS LTD | Published : 2013
OBJECTIVE: We aimed to identify the baseline prevalence of cardiac dysfunction in patients commencing clozapine, assess adherence with echocardiographic monitoring recommendations, and evaluate the utility and cost of echocardiographic monitoring for the development of clozapine-associated myocarditis and cardiomyopathy. METHODS: A retrospective longitudinal cohort study was undertaken of 159 consecutive patients from a major tertiary centre commencing clozapine in the period January 2002 to July 2009. RESULTS: Some 73% of patients had a baseline study, and 11% had a six-month follow-up study. Nine patients had abnormal left ventricular function at baseline. Myocarditis was identified in thr..View full abstract
This research was supported in part by an investigator-initiated grant from Hospira.